Stay updated with breaking news from Affordable Generics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In this review, we discuss the most important recent developments in the biosimilars space, including new biosimilar approvals and launches, litigation under the Biologics Price...
While only slightly past the midway point of 2023, it has already been a busy year for developments in drug pricing. Notably, CMS released its final guidance in preparation for price...
'The cost of prescription drugs is simply too high.'
'The cost of prescription drugs is simply too high.'
As the life sciences industry continues to expand and grow increasingly complex, so does its legal, regulatory, and compliance landscape. To help companies and investors navigate the...